Dr. Merry Lynn Tetef MD Medical Oncologist

Dr. Merry Tetef is a medical oncologist in Irvine, California and is affiliated with multiple hospitals in the area, including Hoag Memorial Hospital Presbyterian and Ronald Reagan University of California Los Angeles Medical Center. She received her medical degree from Harvard Medical School and has been in practice for 27 years. Dr. Tetef accepts several types of health insurance, listed below. She is one of 12 doctors at Hoag Memorial Hospital Presbyterian and one of 39 at Ronald Reagan University of California Los Angeles Medical Center who specialize in Medical Oncology.

Are you Dr. Tetef? Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Hematology

Education & Medical Training

UCLA Medical Center
Residency, Internal Medicine, 1987–1990

Harvard Medical School
Class of 1987

Certifications & Licensure

American Board of Internal Medicine
Certified in Medical Oncology

CA State Medical License
Active through 2014

Awards, Honors & Recognition

Super Doctor, SuperDoctors.com

Top MD, Consumers Checkbook

Publications & Presentations

Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer.
Chew, H.K., Doroshow, J.H., Frankel, P., Margolin, K.A., Somlo, G., Lenz, H., Gordon, M., Zhang, W., Yang, D., Russell, C., Spicer, D., Synold, T., Bayer, R., Hantel, A., Stiff, P.J., Tetef, M.L., Gandara, D.R., Albain, K.S.

Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis.
Morgan, R. J., Newman, E. M., Doroshow, J. H., McGonigle, K., Margolin, K., Raschko, J., Chow, W., Somlo, G., Leong, L., Tetef, M., Shibata, S., Hamasaki, V., Carroll, M., Vasilev, S., Akman, S., Coluzzi, P., Wagman, L., Longmate, J., Paz, B., Yen, Y., Klevecz, R.

High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival.
Somlo, G., Doroshow, J. H., Forman, S. J., Odom-Maryon, T., Lee, J., Chow, W., Hamasaki, V., Leong, L., Morgan, R., Margolin, K., Raschko, J., Shibata, S., Tetef, M., Yen, Y., Simpson, J., Molina, A.

See all 26 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • BCBS California CaliforniaCare HMO
  • BCBS California PowerSelect HMO
  • BCBS California PPO
  • Blue Shield California HMO
  • Blue Shield California PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Health Net California Large Group PPO
  • Health Net HMO - Employer Group
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PHCS PPO - Kaiser
  • Multiplan PPO
  • Pacificare HMO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Report a Correction — If you are aware of information on this page that is out of date or incorrect, please let us know.

Patient Advice & Support


See More
Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Nearby Medical Oncologists

See all Medical Oncologists near Irvine, CA See all Medical Oncologists in California

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.